{
  "cluster": {
    "id": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
    "title": "FDA Rejects Rare Disease Drug, Citing Insufficient Data, in Surprise Move",
    "articleIds": [
      "4b8ae1d2-2e14-4fb1-9544-59777e5f0fa5",
      "68a0abf2-d7a5-4530-876d-3335950b0c71",
      "7d06d7e2-f681-4c57-8a50-7a92dc7332a0",
      "9a8e32d1-c3a6-4a84-bd74-f0f1a225089c",
      "b78fadb6-3604-40b9-88ca-72e6e2399107"
    ],
    "redditPostIds": [],
    "createdAt": "2026-02-26T20:48:38.992Z",
    "updatedAt": "2026-02-26T20:48:56.779Z",
    "articleCount": 5,
    "sourceCount": 1,
    "topSources": [
      "STAT News"
    ],
    "importance": 25,
    "status": "active",
    "centroid": [
      0.014218553450000001,
      -0.00964796475,
      -0.01235177615,
      0.06711539525,
      0.00910784125,
      0.012988073699999998,
      -0.04802477175,
      0.01579350085,
      0.03043215975,
      -0.029842366749999995,
      0.023830233,
      -0.05441539,
      -0.027404640999999997,
      0.012785845350000002,
      -0.0016100332749999998,
      -0.03478856875,
      0.040169972250000005,
      -0.023865336,
      -0.018305737875,
      0.020549723375000002,
      0.01036715665,
      0.019272707025,
      -0.004573046999999999,
      0.012096775149999999,
      0.005719309949999999,
      -0.0192024835,
      0.01302748325,
      -0.033095164499999996,
      0.016697848,
      0.0121209662,
      0.035336677,
      -0.024454815749999997,
      -0.0172085495,
      0.011182791,
      -0.00693217,
      0.005241508325,
      0.027573508249999996,
      0.0009957587500000003,
      0.01821168155,
      0.01637222595,
      -0.01179540125,
      -0.0152473315,
      0.04495360625,
      0.0730050975,
      -0.02967044175,
      0.01503635145,
      -0.00778828675,
      -0.0848866625,
      -0.0008191432750000005,
      -0.011550542025,
      -0.02223076975,
      0.04902197275,
      -0.03932557225,
      0.0428902755,
      -0.0377710485,
      0.003455412975,
      0.0067131552749999995,
      0.01719830075,
      -0.02484514125,
      0.0104694409,
      -0.0027069462175,
      -0.01753018085,
      0.02741592325,
      -0.0005052233099999999,
      -0.042025991,
      -0.004649855575,
      -0.01308793,
      0.015449506125,
      0.0048174086500000005,
      0.01596785915,
      0.0030162814999999997,
      0.0006961098749999999,
      0.00829829375,
      0.049400232249999995,
      0.0440333735,
      -0.0181909595,
      -0.017970086375,
      0.0768842,
      0.01554671065,
      -0.01004925925,
      -0.009189084049999999,
      0.00667282985,
      -0.003686791750000001,
      0.006908668935,
      -0.027591566125,
      -0.02436005525,
      -0.043331756500000006,
      -0.016598256275,
      -0.007319937999999998,
      -0.030249335250000002,
      -0.04119177625,
      -0.0020358184999999997,
      -0.06212023625,
      0.05401244325,
      -0.0233966195,
      0.013952334424999999,
      -0.030676367249999996,
      0.0075175558325,
      -0.01811961425,
      -0.011159468249999999,
      0.0087926503,
      -0.018528019,
      -0.033478225,
      -0.0024480273665000007,
      0.042094366999999994,
      0.02913825225,
      0.0011752721999999998,
      0.0009363237,
      0.0562849595,
      0.0061711544249999995,
      0.024065397500000002,
      -0.0402266675,
      -0.03699783875,
      0.03123419625,
      -0.03475854575,
      -0.0651754495,
      -0.034759727000000004,
      0.026779417175,
      0.022697748175,
      0.03561020225,
      0.0003765238750000001,
      0.045002186,
      0.006066195999999999,
      -0.012579169750000002,
      0.041532133500000006,
      -0.019191676625,
      0.064368675,
      0.00872369725,
      -0.0244282835,
      -0.05949131525,
      0.0361450475,
      -0.0019513434500000003,
      0.026069338499999997,
      -0.02803512825,
      -0.04274608275,
      -0.0062550795,
      -0.014046055575,
      -0.021824582000000002,
      -0.029379149499999997,
      -0.02906283575,
      -0.01088501075,
      0.0007225691749999997,
      -0.0045516505499999995,
      -0.02028028525,
      -0.012367256549999999,
      -0.0252287225,
      0.017501775,
      0.0008535499999999998,
      -0.0041538501,
      -0.0008903573999999997,
      0.023924382,
      0.02619206375,
      0.019395368174999997,
      0.0020741749125,
      0.006400488249999999,
      -0.031840220575,
      0.02281246445,
      0.05421194575,
      -0.007728416575,
      -0.0279010385,
      -0.00414214581,
      0.012473256325000001,
      -0.0018495525000000006,
      -0.0381973065,
      0.0006676372999999992,
      0.042940137249999996,
      -0.006692474699999999,
      -0.040013262749999993,
      -0.04388535925,
      0.020644000625000002,
      -0.009928079675000001,
      -0.052912589,
      -0.021891612249999998,
      0.0019402668500000002,
      -0.014574889249999999,
      -0.02856359645,
      0.01934661225,
      0.00010726962500000022,
      -0.016898213824999998,
      -0.073018115,
      -0.018951669,
      -0.007305960425000001,
      -0.0094608878,
      -0.003867333865,
      0.01632253175,
      -0.0041228354749999994,
      -0.02635005,
      0.025702568500000002,
      -0.01695007275,
      -0.0279990865,
      -0.0122930105,
      0.0005388651325000003,
      0.0431208575,
      0.0033457754000000006,
      -0.038407624249999994,
      -0.0485659445,
      0.034133332249999995,
      0.004742928,
      0.0080176795,
      -0.01815645775,
      -0.015137334985,
      -0.0058296899,
      -0.012073291290000001,
      -0.0019986796750000005,
      -0.024199935,
      -0.0463501775,
      0.0003900798325,
      0.038283135749999996,
      -0.010572462724999999,
      -0.01610542305,
      0.027760546999999997,
      -0.008552587274999999,
      0.0061175889,
      0.02119054425,
      0.0085186135425,
      -0.03215539325,
      -0.02971346775,
      0.03272921575,
      0.04586474025,
      0.087768531,
      0.012591511574999999,
      0.02495924325,
      -0.01344002815,
      0.02484285225,
      -0.01105623159,
      0.01305671805,
      0.03735605075,
      -0.012201751924999999,
      -0.010605998075,
      -0.002777776235000001,
      0.016105060150000003,
      0.0111293649,
      -0.0007794672499999997,
      -0.028263052,
      -0.008959930375,
      -0.037561733,
      0.042415961,
      -0.015963705850000003,
      0.0342737095,
      -0.03839922975,
      0.02486471925,
      -0.0032036770749999995,
      0.03641737675,
      0.010623621449999999,
      -0.01221133225,
      0.0019384238250000003,
      -0.00493984275,
      -0.08098701900000001,
      -0.0017753926249999999,
      0.01870682675,
      0.0201926455,
      0.03868871875,
      0.0228862835,
      -0.003985620355,
      -0.010621252500000001,
      -0.010361954875,
      0.04424933625,
      -0.017295610125,
      -0.03345041875,
      -0.010432900375,
      -0.034091566499999996,
      0.014703342000000001,
      -0.004366413675,
      -0.035626541,
      -0.055944627000000004,
      0.0286289525,
      0.045285688500000004,
      -0.0190026087,
      -0.00604802065,
      0.011569245675000003,
      -0.0023374654750000006,
      -0.0074751486,
      -0.006307719375,
      0.019910951250000003,
      -0.017283528425,
      -0.034609435,
      0.025444209750000002,
      0.011935605075,
      -0.034928347250000005,
      0.0406957715,
      -0.0069160624999999995,
      0.00476527575,
      -0.025433614,
      -0.06527012700000001,
      0.000393473675,
      0.0028079378249999997,
      0.022955516725,
      -0.01014493585,
      -0.010032374375,
      -0.003512248525,
      -0.014109220289999998,
      -0.002971328075,
      0.01691091775,
      -0.04457680675,
      0.00619699603,
      -0.028850217499999997,
      -0.011231219150000001,
      -0.003426445500000001,
      -0.0180677465,
      -0.00342435916,
      0.030797135424999997,
      -0.04399941275,
      0.04797270175,
      -0.026294147875,
      0.02924445725,
      0.0342664915,
      -0.018506103,
      -0.039363406749999996,
      -0.0320698345,
      0.036024050749999995,
      0.001178205175,
      -0.011873378799999999,
      0.033515329,
      -0.052660540750000005,
      0.02420731775,
      -0.0037061149999999994,
      0.03520072375,
      -0.052253939,
      0.0047506905,
      0.0091027915,
      -0.022225004675,
      -0.016694272332500003,
      0.01459729475,
      0.027292498,
      -0.01566381725,
      -0.039069832,
      0.010660019599999999,
      0.0195783164575,
      0.03547373775,
      -0.03749905025,
      0.0024256720750000004,
      -0.0275341415,
      -0.0016671933750000002,
      -0.0006647498174999996,
      -0.01728727625,
      -0.03468489175,
      -0.0026695861249999998,
      0.011854715,
      0.027483169174999995,
      0.0030200699925,
      -0.027806499499999998,
      -0.028768127249999997,
      -0.03859990425,
      -0.0191350565,
      0.030525974,
      -0.010040716575,
      -0.015015529750000001,
      -0.0208293215,
      -0.029951554,
      0.040140905000000004,
      -0.04953193325,
      0.0032877587499999996,
      0.0021326709749999993,
      0.011055996,
      -0.0017012402000000002,
      0.0046641545999999996,
      -0.00527953125,
      0.0014015747499999994,
      -0.006047474499999999,
      0.012643429500000001,
      -0.013059721875000001,
      0.020876417925,
      -0.015597625150000002,
      0.045871789,
      0.0170838332775,
      0.01292863125,
      -0.036647554,
      -0.053027458,
      -0.01710392715,
      -0.047003642750000005,
      0.0279088335,
      -0.0250442155,
      -0.014555829575,
      0.0229435555,
      -0.01765057625,
      0.0121080733,
      -0.0201719615,
      0.02639306825,
      0.03250473325,
      0.037060697749999996,
      0.012401382350000002,
      0.006039382100000001,
      -0.0004792706000000003,
      -0.017765266,
      -0.00260453932,
      0.046257360250000004,
      0.017648656750000002,
      -0.005329169,
      -0.0909846075,
      0.0033266852500000005,
      0.010040748950000001,
      -0.02197840725,
      0.0033411702500000004,
      0.010786414425,
      -0.022791294,
      0.05636664925,
      -0.05349173,
      0.05381028875,
      0.0662160945,
      0.006657465325,
      -0.007131479175,
      -0.04764016375,
      -0.024324678,
      -0.010545843374999999,
      0.011994517825,
      0.033187997250000004,
      0.009350481835,
      0.008557560375,
      -0.011200053849999999,
      -0.004355978975000001,
      -0.01899202325,
      -0.009553207199999999,
      0.039014696,
      -0.053871676,
      0.038174419999999994,
      -0.00271354825,
      -0.02809472215,
      0.06685966400000001,
      -0.01926965275,
      0.045902863749999995,
      0.0171286545,
      -0.03300994075,
      0.013579460925,
      -0.01390186975,
      -0.0262056515,
      -0.00661669475,
      0.049927477250000005,
      -0.055325247499999994,
      0.028535523025,
      -0.00967997045,
      -0.00966889735,
      -0.0019568502749999998,
      -0.024385733625,
      -0.0410659005,
      0.0080765405,
      0.005395581475,
      -0.013022563575,
      0.008850331625000001,
      -0.00965123575,
      -0.0111761177,
      -0.049748653999999996,
      -0.00016010199999999964,
      -0.02662654625,
      -0.04746510625000001,
      -0.032005860750000004,
      -0.033886901999999997,
      0.035147692,
      0.028554987,
      -0.025187075000000003,
      -0.00554107995,
      0.01512697465,
      -0.039914584,
      -0.018903539849999998,
      -0.03481672575,
      -0.054881016500000004,
      -0.006742966475,
      0.015214277,
      -0.013709605625000001,
      -0.0193769101,
      0.02414839625,
      0.024246438599999996,
      0.011933252475,
      0.036358698,
      0.021504329695,
      -0.02789913225,
      -0.00423393865,
      0.031035834,
      0.017518248,
      -0.0199692785,
      -0.023831825,
      -0.0137008255,
      -0.033514688749999993,
      -0.0005169781499999994,
      -0.0008383825500000001,
      -0.009213723727500001,
      0.0019126707500000005,
      -0.008356052975,
      -0.02162700675,
      0.012612300549999999,
      0.008730254974999999,
      0.0174927141375,
      0.0160743445,
      0.0027216584249999997,
      0.018013614,
      0.0274364345,
      -0.03988941125,
      0.024874588250000003,
      0.0061465361,
      -0.05092415225000001,
      0.03428610775,
      0.05428640124999999,
      -0.013623369,
      0.0254454059,
      -0.0173649645,
      0.013711486275,
      -0.0060125055,
      -0.0005841166749999999,
      -0.009850742249999999,
      -0.01781274025,
      -0.0231538245,
      0.024722593499999997,
      -0.0004122512499999994,
      -0.01995830675,
      0.034396212999999995,
      0.03274573325,
      0.0325466195,
      -0.0191050655,
      0.0627767205,
      0.005328574400000001,
      0.03373616775,
      0.005213597499999999,
      0.020876675999999997,
      0.004432962125,
      -0.0203177248,
      -0.022768253000000002,
      0.025003545500000002,
      0.00749485025,
      0.013910840575,
      -0.01001761183,
      -0.012606782,
      -0.004395688902499999,
      0.028758196749999996,
      -0.02824722625,
      0.02256472825,
      -0.01417635125,
      -0.023442763499999998,
      -0.03421327775,
      0.02633319325,
      -0.017302384,
      -0.04099418875,
      0.004647781225,
      -0.006966866,
      -0.0029684169000000005,
      0.036987425000000004,
      -0.004057836825,
      0.012770687075,
      -0.011697783250000001,
      -0.00838042395,
      -0.01565498475,
      0.0026477275,
      -0.0026978438250000003,
      -0.01378235715,
      0.033092562,
      0.00518845295,
      0.005607025924999999,
      -0.010602239325,
      -0.0085411635,
      -0.012023776,
      -0.0087151691,
      0.0064962832750000005,
      0.036307804,
      0.014589686625,
      0.0313574175,
      0.001897937350000001,
      -0.004645018275,
      0.0003657014500000001,
      -0.015926278425000003,
      -0.018511851750000002,
      -0.0083589815725,
      0.00402124605,
      0.023040959399999998,
      -0.002410696225,
      -0.0113589565,
      -0.0187081516,
      -0.035403238999999996,
      0.0035222167000000006,
      0.0035453653000000005,
      0.00441552635,
      -0.0208409255,
      0.04337287075,
      0.0057255859999999995,
      0.021154252499999998,
      -0.02048510375,
      -0.02756195225,
      0.04957693075,
      0.009627195250000001,
      -0.00300851254625,
      -0.0357081405,
      0.019697448275,
      0.018089388499999998,
      -0.004969043100000001,
      -0.026611937500000002,
      -0.028849324249999996,
      0.03214988075,
      -0.023756502,
      0.0639199625,
      0.013732030375,
      0.012720917200000001,
      -0.01288516525,
      0.012333153,
      -0.00958532545,
      -0.013866011900000001,
      0.0091875532,
      0.012298891325000002,
      0.019040585875000002,
      0.00223157705,
      0.027120909999999998,
      -0.02994179275,
      -0.014330596775,
      0.02048291745,
      0.02104850725,
      -0.0104333701875,
      -0.002360325925,
      -0.025346243249999997,
      -0.027110016,
      0.02615094275,
      0.007669563349999999,
      -0.017927084000000003,
      0.03536921325,
      -0.0014662873999999998,
      0.024966986000000004,
      0.0081375502825,
      -0.036995227500000005,
      -0.027539386,
      -0.02431281475,
      0.0067203961,
      -0.024833085125,
      -0.010770954499999999,
      0.028524571250000002,
      -0.02328886075,
      -0.033579580250000005,
      -0.006783830424999999,
      -0.020709087,
      -0.010845645325,
      -0.013529366599999999,
      0.0100411857425,
      0.004276524049999999,
      -0.013049676299999998,
      0.0471670135,
      0.024279826999999997,
      0.02801847925,
      0.0178493739,
      -0.018392716275000002,
      0.039653375500000004,
      0.011730242875,
      0.01249463425,
      -0.0008100599499999995,
      0.00314721936,
      -0.01128242085,
      0.008198604524999998,
      0.033500942000000006,
      -0.01506875275,
      0.016269875099999997,
      -0.014288073749999998,
      -0.019100561,
      -0.0148041075,
      -0.004648435874999999,
      -0.03279898675,
      -0.006514945,
      -0.027363623,
      -0.012841410250000001,
      -0.0367063365,
      0.023277600000000002,
      0.02401751525,
      -0.0095393328,
      -0.010200825499999998,
      -0.0171191205,
      -0.0048226996,
      0.0244924225,
      0.031161711249999998,
      -0.0021780233425,
      0.024124885,
      0.0038636661699999997,
      -0.0214726505,
      -0.011566985549999999,
      0.017749365524999998,
      0.02985652375,
      0.006155635934500001,
      0.01571012925,
      0.0176677242,
      0.027706381,
      0.0036852600624999996,
      0.02878915125,
      -0.016754261,
      0.000778811425,
      0.00007215632499999966,
      0.0042483692,
      -0.028215890925,
      -0.027121638,
      0.01872604325,
      0.0138014957,
      -0.0021706203375,
      -0.0206264909,
      0.0028360341499999997,
      -0.0071396148,
      -0.0238849935,
      0.01849563750875,
      0.01718679975,
      0.008931352,
      0.03668948600000001,
      0.01808965325,
      0.0018550861500000004,
      -0.00016915270000000013,
      -0.0167353895,
      -0.0016839283750000006,
      -0.028494637,
      0.0037081642499999998,
      0.013012745725,
      -0.02751889475,
      -0.06257880525,
      0.008617232874999999,
      -0.024384897500000002,
      0.012477417574999998,
      -0.020906885,
      -0.020567586,
      0.007053251049999999,
      0.018912999099999998,
      -0.01377601233875,
      0.0252438325,
      -0.01540205815,
      -0.0142285316,
      0.0012021438500000002,
      -0.018946635125,
      0.005772706674999999,
      -0.0044979702000000005,
      -0.026657105,
      0.014040894824999999,
      0.00713884805,
      0.0079684214,
      0.042461989500000005,
      0.004891881125,
      -0.0300533595,
      0.010432115499999998,
      0.00389947045,
      0.021770790325,
      0.004363014175,
      -0.02722459525,
      0.04215660025,
      -0.0086016329075,
      0.0034947853999999995,
      -0.034454397,
      -0.023893825375,
      -0.029485618724999996,
      -0.017116409399999997,
      -0.0045874122,
      0.0060228206425,
      -0.00864944675,
      -0.02017925325,
      -0.039721178,
      0.007629394875000001,
      -0.00785865945,
      -0.022586879749999997,
      -0.004998180625,
      0.026194706499999998,
      -0.007096153975,
      0.006721810375000001,
      0.032569014,
      0.0139044454,
      -0.0009345108749999999,
      -0.062029357,
      0.012821554924999999,
      0.0136671435,
      -0.023896207750000002,
      0.012048183175000001,
      0.007825399899999998,
      -0.05366871399999999,
      -0.00646660195,
      0.004921079100000001,
      -0.0254899935,
      -0.0287358105,
      -0.021689888,
      0.00409088145,
      0.0037788207249999997,
      0.01754227685,
      -0.01673200375,
      0.014694323749999998,
      0.004182640175,
      0.037676444,
      -0.0089312343,
      0.014836124,
      -0.0103249708,
      -0.014542906750000001,
      0.02982097875,
      -0.0034237976499999997,
      0.0027556342499999997,
      -0.00737097175,
      -0.017236694,
      0.007404874125,
      -0.002205869175,
      0.011009882374999998,
      0.01022497865,
      0.0176669985,
      -0.004118412425000001,
      0.027366279675,
      -0.02671295505,
      -0.0140829025,
      0.0110983312,
      0.001978462925,
      -0.04862698775,
      0.024246781,
      -0.03682306725,
      0.007309505085000001,
      -0.0141110036425,
      0.0303575665,
      -0.005952846125,
      0.0148013244,
      0.022800038,
      -0.096278174,
      0.0217604615,
      0.011494999200000001,
      -0.020164927,
      -0.00031308087500000006,
      -0.01029639025,
      -0.006252994225,
      0.03201811125,
      0.01983839415,
      -0.0038230745000000003,
      0.055496260750000005,
      -0.0050819375,
      -0.01515164075,
      -0.00211599165,
      0.02631437425,
      0.008012355374999999,
      -0.0260659395,
      -0.0228796587625,
      -0.021175456375,
      0.006933402075000001,
      -0.006395306460000001,
      0.006008616375,
      -0.021205233999999996,
      0.03442820475,
      0.00515417086,
      0.017203352175,
      -0.016997735875,
      0.006857737524999999,
      -0.02815261025,
      0.012310310525000001,
      0.0193956615,
      0.005813870099999999,
      -0.0336071555,
      0.014577968549999999,
      0.0031212864999999998,
      -0.02519445125,
      0.001273996675,
      0.017965174800000004,
      -0.011313979475,
      -0.00594405725,
      0.01587398075,
      -0.011764766325000002,
      -0.0012312538000000006,
      0.0027997403750000005,
      -0.03399759475,
      -0.009232168150000001,
      -0.0191353527,
      -0.007456918775,
      0.013820151,
      -0.01328629743,
      -0.007545013625,
      -0.039997458750000006,
      -0.0085657398,
      -0.010774703675,
      0.003070213175,
      -0.02252518275,
      -0.0042279102499999995,
      0.005788579500000002,
      -0.002283931825,
      0.02495036675,
      -0.008237592975000001,
      0.007978069999999999,
      0.025171734249999998,
      -0.0006486938250000001,
      0.0015566392500000002,
      0.024655303875,
      -0.0365043775,
      0.015157381175,
      -0.02147240975,
      0.001605713825,
      0.001822632175,
      0.010288592425,
      -0.008689112225,
      0.01517591925,
      0.005446220825,
      -0.004659939649999999,
      0.01272346345,
      -0.036360670000000005,
      0.0095088581,
      -0.006699004775,
      0.0150795305,
      -0.0171501285,
      -0.0349828835,
      -0.018508869487500003,
      -0.03634451725,
      0.02723983375,
      0.003856819,
      0.029968396999999997,
      0.02847611775,
      -0.007021260775,
      0.012937964599999999,
      -0.025295762075000002,
      -0.0173878445,
      -0.004836300849999999,
      -0.014795956324999998,
      -0.016077619,
      -0.0028460842499999995,
      0.015924080299999997,
      0.028246916249999997,
      -0.023427991250000002,
      0.023738882,
      0.001804862125,
      0.0089367233,
      -0.007547884500000001,
      -0.04006997925,
      -0.0033769042825000004,
      0.03400523975,
      -0.0104916985,
      -0.011999863699999998,
      0.008437593024999999,
      0.0073248453924999995,
      0.01512233904,
      0.025826264,
      0.019850863000000003,
      -0.018856257249999998,
      -0.0016845429625000003,
      0.0271336685,
      -0.026983113,
      -0.00011587494999999986,
      0.01763254575,
      0.001099795,
      -0.0015535358499999998,
      -0.016359772550000002,
      0.02356997875,
      0.00355710385,
      -0.0036950564,
      0.020218276,
      0.019005154625000003,
      0.02094824425,
      0.02153603275,
      -0.01038844645,
      0.0360879105,
      -0.0034519068125,
      -0.030876490762500004,
      0.0158115591,
      0.016617361249999997,
      0.02159356625,
      0.010257438125,
      0.009261219250000001,
      0.017234120625000002,
      0.0068171185,
      -0.005957851775,
      -0.0142445845,
      0.0054464151249999995,
      0.029731411,
      -0.00677449709,
      -0.05754469449999999,
      0.0029522837999999994,
      -0.010139487749999999,
      -0.01002951975,
      0.0041658589,
      0.017617896,
      0.0038473442749999997,
      0.03774683225,
      0.019622899675,
      0.040276441749999996,
      -0.0061262533125,
      -0.0272525385,
      -0.032159007249999996,
      0.008900029525,
      -0.01027477855,
      0.03854905425,
      -0.01699479875,
      -0.018609711874999997,
      0.008805663750000001,
      -0.02000332325,
      -0.039529751,
      -0.025414032250000003,
      0.01763376675,
      0.0022715223000000007,
      -0.00003911124999999996,
      -0.04796979075,
      0.0320444445,
      -0.012922877925,
      -0.014091840925,
      0.00729808775,
      0.0054511993249999995,
      0.023436356925,
      0.020841954500000003,
      0.02350116775,
      0.0314038765,
      -0.0010142667499999998,
      0.0029286583749999996,
      0.0018245555750000001,
      0.009134766925,
      -0.00624108215,
      0.003971549055,
      -0.007765587575,
      -0.016402711175,
      -0.019484295125,
      0.01674261955,
      0.0307340405,
      0.0086421322,
      0.011131153250000001,
      0.015653354125,
      0.004197584825,
      0.011384212500000001,
      0.0140488815,
      -0.00986279225,
      0.007990999625,
      -0.02526979225,
      0.023202772,
      0.034357200000000004,
      -0.010100160179999998,
      -0.005665368025,
      0.01834916675,
      0.05016629975,
      -0.009308726,
      -0.0367483635,
      0.010369443025,
      -0.0122893304,
      0.0020815355625,
      -0.022034915,
      0.06671097749999999,
      -0.0222459375,
      0.0030735323249999995,
      0.013768913749999999,
      -0.01643656025,
      -0.05462514725,
      -0.0066071463375,
      -0.015547291875,
      -0.020751228,
      0.0023013418749999997,
      0.007478559,
      0.01369183775,
      0.008377683825,
      -0.0072120774249999995,
      -0.017386366075,
      0.0089809651,
      0.00388858135,
      -0.005140161900000001,
      0.00799535535,
      -0.0043939408,
      0.039303889249999995,
      0.0141798945,
      -0.008016889925,
      0.04056996,
      -0.01433556725,
      0.0105385283,
      0.016460229974999997,
      0.042696554250000004,
      -0.005357955825,
      0.007391132825,
      -0.0251382146,
      -0.008336929825,
      0.03859909275,
      0.0473866385,
      -0.017607497625,
      -0.00653928445,
      -0.0201707875,
      -0.03182113,
      0.030728567749999998,
      0.0029390708500000003,
      0.0067224040750000005,
      0.03862940425,
      0.0036026693999999995,
      0.024854139750000004,
      -0.009215127715,
      0.0032354693499999994,
      0.004344414475000001,
      -0.0009174077349999997,
      -0.009729824149999998,
      0.0031272519,
      0.01598839,
      0.0017459361624999998,
      -0.014376265817500001,
      -0.0124795555,
      -0.0065432992,
      -0.0049041026500000005,
      0.03991380825,
      0.00396927155,
      0.005391773575,
      -0.0011784529999999999,
      0.028371209249999998,
      -0.011596938374999997,
      0.008943406925,
      -0.01674038475,
      0.006224638375000001,
      -0.007311145681250001,
      -0.0112379928,
      0.02501868375,
      0.009871672024999998,
      0.0016212289,
      -0.0026813770999999996,
      -0.02804830625,
      -0.007988199,
      -0.0010412199999999996,
      -0.042538456,
      -0.023045957,
      0.0025952998499999998,
      0.009712114375,
      0.01058895675,
      -0.005733713999999999,
      -0.001556929825,
      -0.032887359500000005,
      -0.0057985782,
      -0.011769187899999999,
      0.00729616145,
      0.008330739775,
      0.02839186225,
      0.012777135275,
      0.0167705011,
      -0.0005920998750000001,
      -0.005689464799999999,
      -0.0053257731,
      0.007274557300000001,
      -0.018565116,
      -0.02906909075,
      -0.00696534674,
      0.01967853465,
      -0.044480660000000005,
      -0.0080101817,
      0.0005630437499999999,
      -0.0144679756575,
      -0.0016644412499999999,
      0.013706070124999999,
      -0.006145838149999999,
      0.03567722325,
      0.006770017000000001,
      -0.020719981875,
      -0.022108421,
      0.00316180175,
      -0.01817532875,
      -0.016788927999999998,
      -0.03276991025,
      0.037142905749999997,
      0.02247971025,
      0.0056998486074999995,
      0.012218532575000001,
      0.0041834747250000005,
      0.02202206125,
      0.0046242893500000005,
      0.01837035225,
      -0.01277323,
      0.0243736435,
      0.02311615675,
      0.01055392535,
      0.0005003857500000004,
      0.01971012125,
      -0.024552675925,
      -0.018459047925,
      -0.02299370685,
      0.010043917500000001,
      0.012383809125,
      0.0227128005,
      -0.012191231875,
      0.009513855,
      -0.02845877925,
      -0.021033235499999997,
      0.0070416835,
      0.09371257200000001,
      -0.011308325375,
      0.01476853225,
      0.033329998,
      0.007426569175,
      0.0007138829675000001,
      -0.01734250425,
      0.0206667276625,
      -0.0141900977,
      0.0002463022000000004,
      -0.005766835425,
      0.014271427825000002,
      0.009589623549999999,
      0.006632862235,
      0.024695327000000003,
      0.011046430825,
      0.00846547445,
      -0.0074414310825,
      -0.027952107999999996,
      -0.01029194871,
      0.00458442825,
      0.032895581,
      0.002876751275,
      -0.05183910725,
      -0.0015125009125,
      -0.0265774295,
      0.0478165455,
      0.012362622,
      -0.019005247875,
      0.0091402495,
      0.027209282,
      -0.006021307125,
      0.00160078015,
      0.04197805325,
      0.0023757108749999996,
      -0.02686892475,
      -0.0041751839675,
      -0.025790918500000003,
      -0.024633895750000002,
      -0.024859866499999998,
      0.0010012258925000002,
      -0.0060954867585000004,
      0.02011791725,
      0.0014900538749999994,
      0.0023265602750000003,
      0.005172548825,
      -0.02479994825,
      0.011763156525,
      -0.011924697724999999,
      -0.014661232849999999,
      -0.04282280075,
      -0.007471609299999999,
      0.004746040374999999,
      -0.005718494525,
      0.025744858,
      0.002505874125,
      0.014263133875,
      0.02269904225,
      0.023774745,
      -0.008642308125000001,
      -0.0471224925,
      0.00907163835,
      -0.023481273625,
      0.0015382050500000002,
      -0.0004428259500000001,
      -0.020628157874999997,
      0.029620205250000003,
      0.00863655185,
      -0.021206157499999996,
      -0.0074737233775,
      0.012534113,
      -0.007041194025,
      0.02984228125,
      0.00978996575,
      0.0142172388,
      0.00819889925,
      0.00864881375,
      0.017187593,
      -0.01964391425,
      -0.0011239446249999997,
      -0.017781596175,
      0.015143037425000002,
      0.046816592500000004,
      -0.010849509899999998,
      -0.03422295575,
      0.02843587575,
      0.00021323362500000028,
      0.015452626075,
      -0.027737456075,
      -0.045451548749999994,
      -0.0160240195,
      0.02241969475,
      0.008127419900000002,
      0.02426231425,
      -0.00367466825,
      0.0024033792249999997,
      -0.021124598925,
      -0.011862893925,
      -0.0028899849999999994,
      -0.00001856509499999969,
      0.0016419987250000003,
      0.012366531875,
      -0.024647179999999998,
      0.0012155302499999997,
      0.0016860369249999997,
      0.01955636375,
      -0.06033177525,
      -0.022132905325,
      0.021654080500000002,
      -0.025790327,
      -0.03658176075,
      0.023233750750000004,
      0.002628305249999999,
      0.003398872275,
      0.0028959339250000005,
      0.02327988625,
      -0.012970854425,
      -0.00400911575,
      -0.0081012537,
      -0.027819407749999997,
      -0.0213995135,
      0.009161110075,
      0.003916654430750001,
      -0.031943248325,
      0.00397842945,
      -0.023018397,
      0.04889352275,
      0.02095416725,
      0.004631233,
      0.0044122818,
      0.00530911725,
      0.012220124875,
      0.00836153125,
      -0.007383792750000001,
      -0.0012168570750000001,
      0.049858848,
      -0.02480965,
      -0.0039834062425,
      0.02267059175,
      0.0096705419,
      -0.0017361255000000002,
      0.00414521435,
      -0.002847887,
      0.0076435667500000005,
      -0.007139878375,
      -0.025679289,
      -0.01562941875,
      0.010809177825,
      -0.03201020975,
      0.01664470175,
      -0.018689271,
      0.008419293175,
      -0.005255806225,
      0.00398691184,
      0.021621744749999998,
      -0.013369438,
      0.01443137848,
      -0.02612859225,
      -0.0289795991,
      0.003354262875,
      -0.013054781750000001,
      -0.020458663250000002,
      -0.02470183275,
      -0.0136087075,
      0.006471210225,
      0.013471988899999999,
      -0.024309000000000004,
      0.007920291125000001,
      0.010356011600000001,
      0.006177354825,
      -0.006214751050000001,
      -0.008837178236500001,
      0.0162299666075,
      0.002122509975,
      -0.01820546981,
      -0.0055676268350000006,
      -0.0056993730825000005,
      0.01982531285,
      -0.030685672999999997,
      0.02070881435,
      -0.0037743407499999998,
      -0.00006099732500000014,
      0.02430452475,
      -0.03024886325,
      0.0034539698999999997,
      0.004090645975,
      -0.014564334575,
      -0.019041635125,
      -0.035488136,
      -0.0188698395,
      -0.0026565077499999994,
      -0.01162586485,
      -0.011592910750000001,
      0.024090657499999998,
      0.03985725375,
      0.0082664694,
      -0.023516371875,
      0.0069448116499999995,
      0.00026596574999999934,
      0.0023172543999999996,
      -0.0125172329625,
      0.028379126749999997,
      -0.00943362625,
      -0.012855395125,
      -0.0170689945,
      -0.03064483825,
      -0.0232061955,
      0.00023689965000000006,
      -0.009293542650000002,
      -0.0089814709,
      0.011933614700000001,
      -0.01465104825,
      -0.00973994955,
      0.008436947025,
      0.0037083824000000002,
      -0.0055235768,
      -0.01629806375,
      0.02573242225,
      0.017278461699999997,
      0.02224542125,
      0.013269977575000001,
      -0.010412132374999997,
      -0.014864667500000001,
      -0.02040194725,
      0.02086412775,
      -0.01986999625,
      0.02681724275,
      -0.006942497425,
      -0.0111307495,
      -0.013005212674999999,
      0.006420876075000001,
      -0.0045041169200000005,
      -0.01176083975,
      -0.006258418975,
      -0.020121723374999997,
      -0.020956839999999997,
      -0.02027504815,
      -0.02197752925,
      0.0137098525,
      -0.0468466925,
      -0.03466351575,
      -0.004633838249999999,
      -0.007616138999999998,
      0.002288998225,
      -0.027081302,
      0.01736695675,
      -0.01235071125,
      -0.0022092754000000007,
      -0.0221067605,
      -0.0006811380920000004,
      0.021367857500000004,
      -0.007847476075,
      -0.00047273300000000014,
      -0.01045049225,
      0.014989930975,
      -0.0046450963,
      -0.018726775249999997,
      0.0019595601,
      -0.005241333825,
      -0.0057575950725,
      -0.04701581375,
      -0.023332199999999997,
      0.006051517375,
      0.0077185922075,
      -0.0057978995,
      0.01287911885,
      -0.03333051025,
      -0.006489773,
      0.015120204250000002,
      0.013732670500000002,
      0.02048193425,
      0.077637624,
      0.0082045757,
      0.012189115825000001,
      0.0060872723825,
      -0.0061674336250000005,
      0.017688673825,
      0.0038425317499999998,
      0.0142162935,
      0.01845176775,
      -0.0452916015,
      0.018442612125,
      -0.01054794475,
      0.001759307225,
      -0.009557192375,
      -0.02664611175,
      -0.029844605500000003,
      0.015002958149999999,
      -0.0196444345,
      0.005706060775,
      -0.0061400792,
      0.04417298,
      -0.0182063965,
      0.0022716601250000004,
      -0.0190372355,
      0.01189074465,
      0.0006853320750000004,
      -0.06630530825,
      -0.035498127,
      0.00122318285,
      -0.005319603845,
      -0.016558264625,
      0.020280122,
      -0.012229150075,
      0.02647422075,
      0.00205094905,
      -0.0023981536000000003,
      0.0020430318,
      -0.02088291675,
      0.013776878275,
      0.01751925883,
      -0.0013044509999999994,
      0.0005006923750000001,
      -0.015795396,
      0.009818040575,
      -0.0062808930749999985,
      -0.009440626025000001,
      -0.008836762825,
      -0.023372477625000002,
      0.0177774345,
      -0.0098562536,
      -0.0037899328500000003,
      0.013516357925,
      -0.021620384375,
      0.05428928425,
      -0.005961188555,
      -0.04034857125000001,
      -0.0061976476999999995,
      0.007271519650000001,
      -0.007626383874999999,
      0.0024993167500000006,
      -0.021564120500000002,
      0.018730900999999998,
      -0.0004534109749999998,
      0.00895854665,
      -0.026929350749999997,
      0.00198902305,
      0.036757321,
      -0.006058579974999999,
      -0.01318970735,
      0.006999818415000001,
      0.03012883275,
      0.016210981625000002,
      -0.009636420375,
      0.004032519725,
      0.01498818825,
      -0.00283887335,
      0.01972693475,
      0.0133333494,
      -0.0034662720999999994,
      -0.01998066875,
      -0.01364178815,
      -0.009677884050000002,
      0.015414365874999999,
      -0.03115619275,
      -0.011045659875,
      0.010902268325,
      -0.00028283377500000007,
      0.029338297,
      -0.0037769063750000007,
      -0.013135161625,
      0.005530495774999999,
      -0.001111946775,
      0.0035189354125,
      -0.011071445874999999,
      -0.00892695855,
      -0.0033585657499999996,
      0.002528238025,
      -0.005863354125000001,
      0.0296687295,
      -0.004186855,
      -0.013982483225,
      -0.007992698075,
      -0.016600648375000002,
      0.0176742877,
      0.01668060565,
      -0.005059851074999999,
      0.000603661565,
      -0.012013363025000001,
      -0.0294196225,
      0.0238524695,
      0.000824634675,
      0.005641604500000001,
      -0.01021230605,
      0.039046036,
      0.009198527599999999,
      0.020786616825,
      0.0004523857500000003,
      0.02819850225
    ]
  },
  "synthesis": {
    "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
    "narrative": "## State of the Story: FDA Rare Disease Drug Rejections Under New Leadership\n\n### Key Facts\n\nThe FDA has rejected multiple rare disease therapies in recent months, prompting questions about whether the agency's regulatory approach has shifted under new leadership [1][2][3][5]. The most detailed case involves an experimental cell therapy called Ebvallo, developed by Atara Biotherapeutics and Pierre Fabre Pharmaceuticals for a rare blood cancer that occurs after stem cell or organ transplants [3][5].\n\n### The Ebvallo Case\n\nEbvallo was initially on track for FDA approval, with internal agency reviewers recommending clearance in 2025 [5]. The therapy targets a condition affecting approximately 500 patients annually in the U.S., leaving them with \"weeks or months to live\" [3][5]. However, the FDA rejected the drug in January 2026, citing \"deficient\" clinical data [5].\n\nA former FDA employee with direct knowledge of the review characterized this as a \"complete reversal\" and suggested it was \"due to the FDA's new leadership\" [5]. The drug has already received approval in Europe, adding to questions about the agency's current standards [2].\n\n### Commissioner's Defense\n\nFDA Commissioner Marty Makary defended the agency's recent rejections in a CNBC interview on February 26, 2026 [1]. He also defended Vinay Prasad, a top FDA official who oversees the center responsible for many of these rejections [1]. Makary appeared to reference a UniQure gene therapy for Huntington's disease, describing a treatment that required \"drilling a burr hole, literally a hole in people's skulls\" but showed \"no benefit\" after randomization [1].\n\n### Broader Pattern\n\nThe rejections represent part of a series affecting rare disease therapies, suggesting the FDA may be \"setting a higher bar for approval\" despite stated commitments to regulatory flexibility for rare diseases [3]. This creates tension between the agency's public rhetoric about prioritizing rare disease treatments and its actual regulatory decisions [2].\n\n### Timeline\n\n- **2025**: Ebvallo receives positive internal FDA review recommendation [5]\n- **January 2026**: FDA rejects Ebvallo citing deficient data [5]\n- **February 25, 2026**: STAT reports on the Ebvallo rejection details [5]\n- **February 26, 2026**: Commissioner Makary defends rejections in CNBC interview [1]",
    "citations": [
      {
        "index": 1,
        "articleId": "4b8ae1d2-2e14-4fb1-9544-59777e5f0fa5",
        "source": "STAT News",
        "title": "FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad",
        "url": "https://www.statnews.com/2026/02/25/rare-disease-drug-fda-ebvallo/?utm_campaign=rss",
        "quote": "Food and Drug Administration Commissioner Marty Makary defended the agency's recent rejections of rare disease drugs in an interview with CNBC on Thursday. He also defended top FDA official Vinay Prasad, who oversees the center that rejected many of those drugs."
      },
      {
        "index": 2,
        "articleId": "4b8ae1d2-2e14-4fb1-9544-59777e5f0fa5",
        "source": "STAT News",
        "title": "FDA rejection is a reality check on agency rhetoric",
        "url": "https://www.statnews.com/2026/02/25/rare-disease-drug-fda-ebvallo/?utm_campaign=rss",
        "quote": "The FDA's recent rejection of a rare disease cell therapy — despite prior internal support and an approval in Europe — is prompting questions about whether the agency's rhetoric matches its regulatory actions under the new leadership."
      },
      {
        "index": 3,
        "articleId": "4b8ae1d2-2e14-4fb1-9544-59777e5f0fa5",
        "source": "STAT News",
        "title": "Pharmalittle: We're reading about a puzzling FDA rejection, a Lilly weight loss pill, and more",
        "url": "https://www.statnews.com/2026/02/25/rare-disease-drug-fda-ebvallo/?utm_campaign=rss",
        "quote": "An experimental therapy for a rare blood cancer was on the path toward approval by the U.S. Food and Drug Administration last year — with internal reviewers recommending it be cleared — before the agency rejected the drug last month"
      },
      {
        "index": 5,
        "articleId": "4b8ae1d2-2e14-4fb1-9544-59777e5f0fa5",
        "source": "STAT News",
        "title": "A rare disease drug was approvable, then it wasn't. Inside a surprise rejection by the FDA",
        "url": "https://www.statnews.com/2026/02/25/rare-disease-drug-fda-ebvallo/?utm_campaign=rss",
        "quote": "The FDA rejection, on the grounds that clinical data on the drug were deficient, was a 'complete reversal that I can't help but think was due to the FDA's new leadership,' a former agency employee with direct knowledge of the review, speaking on the condition of anonymity, told STAT."
      }
    ],
    "keyDevelopments": [
      "FDA rejected Ebvallo cell therapy despite prior internal recommendation for approval",
      "Commissioner Makary publicly defended recent rare disease drug rejections",
      "Former FDA employee attributes rejection to new agency leadership",
      "Pattern of rejections suggests higher approval standards for rare disease treatments",
      "Tension identified between FDA rhetoric on rare diseases and actual regulatory actions"
    ],
    "generatedAt": "2026-02-26T20:54:48.220Z",
    "model": "anthropic/claude-sonnet-4",
    "tokenCount": 3875
  },
  "claims": [
    {
      "id": "c9913d44-c061-4f3a-94a0-90a41dcd3946",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "An experimental therapy for a rare blood cancer was on the path toward approval by the FDA last year with internal reviewers recommending it be cleared",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 1",
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "2058efc1-5d9b-47cd-90d9-72664ae22312",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The FDA rejected the drug last month",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 1",
        "STAT News Article 2",
        "STAT News Article 4"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "6f21e27f-5ec2-4cd7-ae2e-d487be09f5fc",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The cell therapy is being developed by Atara Biotherapeutics and Pierre Fabre Pharmaceuticals",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 1",
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "e11eb9ae-bc32-4503-aee6-353b1131b108",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The therapy is intended to treat a type of cancer that can occur following a stem cell or organ transplant",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 1",
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "56d6f026-eab0-4c24-97d2-99957c2ead14",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The condition afflicts approximately 500 patients in the U.S. each year",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 1",
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "055c91f5-6469-4653-95f3-613ffa9f03b1",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The condition leaves patients with weeks or months to live",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 1",
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "3392f26e-8829-4f18-bbc0-ff6d94f70be2",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The FDA rejection was on the grounds that clinical data on the drug were deficient",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 1"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "576be053-8e52-4f4d-b9ec-264d9913fc89",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The rejection was a complete reversal due to the FDA's new leadership",
      "status": "disputed",
      "supportingSources": [
        "STAT News Article 1 (former FDA employee opinion)"
      ],
      "disputingSources": [
        "STAT News Article 3 (FDA Commissioner Makary's defense)"
      ],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "69877945-00ac-4599-90cc-5efa78c51dc0",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The drug is called Ebvallo",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "12ae188d-7299-4627-943c-1ca838397b40",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The decision marked one of a series of FDA rejections of rare disease therapies in recent months",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 2",
        "STAT News Article 3",
        "STAT News Article 4"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "3c4c929b-5110-4e3a-b984-6e320f51e8bb",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The agency is setting a higher bar for approval of rare disease medicines",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "95757a9d-7e5f-424c-9f45-a0a3bd378593",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "FDA Commissioner Marty Makary and aides state repeatedly that regulatory flexibility to speed approval of drugs for rare diseases is a priority",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 2"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "17c6180d-f06f-4a40-a254-1ac72272be27",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "FDA Commissioner Marty Makary defended the agency's recent rejections of rare disease drugs in a CNBC interview on Thursday",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 3"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "a7647a86-46d0-46b6-97b4-15da0fcec141",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "Makary defended top FDA official Vinay Prasad, who oversees the center that rejected many of those drugs",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 3"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    },
    {
      "id": "a7c01a37-b3a5-4c71-a0a3-0218a3b4164d",
      "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
      "text": "The therapy had prior approval in Europe",
      "status": "undisputed",
      "supportingSources": [
        "STAT News Article 4"
      ],
      "disputingSources": [],
      "firstSeenAt": "2026-02-26T20:55:05.187Z",
      "lastUpdatedAt": "2026-02-26T20:55:05.187Z"
    }
  ],
  "coverage": {
    "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
    "frames": [
      {
        "name": "Regulatory Reversal/Political Influence",
        "description": "Frames the FDA rejection as an unexpected policy shift driven by new leadership, emphasizing the contrast between initial internal support and final rejection",
        "sources": [
          "STAT News Article 1",
          "STAT News Article 4"
        ],
        "emphasis": "The surprising nature of the rejection despite prior internal FDA support and the potential influence of new FDA leadership under Commissioner Makary"
      },
      {
        "name": "Pattern of Heightened Standards",
        "description": "Presents the rejection as part of a broader trend of FDA setting higher approval standards for rare disease therapies",
        "sources": [
          "STAT News Article 2"
        ],
        "emphasis": "This rejection as one of several recent FDA rejections of rare disease therapies, suggesting systematic policy changes"
      },
      {
        "name": "Regulatory Defense/Scientific Rigor",
        "description": "Frames the rejections as scientifically justified decisions defending against pressure to approve ineffective treatments",
        "sources": [
          "STAT News Article 3"
        ],
        "emphasis": "Commissioner Makary's defense of FDA decisions based on lack of clinical benefit, using specific examples of treatments that showed no efficacy"
      },
      {
        "name": "Rhetoric vs. Reality Gap",
        "description": "Highlights disconnect between FDA leadership's stated priorities for rare disease flexibility and actual regulatory actions",
        "sources": [
          "STAT News Article 4"
        ],
        "emphasis": "The contradiction between agency rhetoric about regulatory flexibility for rare diseases and the reality of recent rejections"
      }
    ],
    "outlierPerspectives": [
      "The specific clinical detail about drilling burr holes in skulls for gene therapy injection as justification for rejection standards",
      "Connection to broader drug pricing issues through TrumpRx and insurance coverage complications"
    ],
    "missingContext": [
      "Specific clinical trial data and endpoints that led to the rejection",
      "Details about the European approval process and why it differed from FDA assessment",
      "Timeline of when new FDA leadership took effect relative to the review process",
      "Comparison of rejection rates for rare disease drugs before and after leadership change",
      "Patient advocacy group responses to the rejection",
      "Financial impact on Atara Biotherapeutics and Pierre Fabre Pharmaceuticals",
      "Alternative treatment options available for the 500 affected patients annually"
    ],
    "generatedAt": "2026-02-26T20:55:03.686Z",
    "model": "anthropic/claude-sonnet-4"
  },
  "community": null,
  "deepAnalysis": {
    "clusterId": "48e6f904-e8e9-48e0-9b8f-f2f3bd4ab757",
    "stakeholders": [
      {
        "name": "FDA Commissioner Marty Makary",
        "role": "Head of FDA under new administration",
        "position": "Defends higher approval standards while claiming rare disease priority",
        "influence": "high"
      },
      {
        "name": "Vinay Prasad",
        "role": "Top FDA official overseeing drug approval center",
        "position": "Implements stricter approval standards for rare disease therapies",
        "influence": "high"
      },
      {
        "name": "Atara Biotherapeutics and Pierre Fabre Pharmaceuticals",
        "role": "Pharmaceutical companies developing Ebvallo",
        "position": "Seeking FDA approval for rare disease therapy already approved in Europe",
        "influence": "medium"
      },
      {
        "name": "Rare disease patient advocacy groups",
        "role": "Representatives of patients with limited treatment options",
        "position": "Likely opposing stricter approval standards that delay access",
        "influence": "medium"
      },
      {
        "name": "Former FDA employees",
        "role": "Industry insiders with knowledge of internal processes",
        "position": "Critical of leadership's policy reversal on rare disease approvals",
        "influence": "low"
      },
      {
        "name": "European Medicines Agency (EMA)",
        "role": "EU regulatory counterpart that approved Ebvallo",
        "position": "More permissive approval standards for rare disease therapies",
        "influence": "low"
      }
    ],
    "predictions": [
      {
        "text": "More rare disease drug rejections will occur as FDA maintains stricter standards",
        "likelihood": "likely",
        "timeframe": "next 6-12 months",
        "basis": "Pattern of recent rejections and leadership's defense of higher standards"
      },
      {
        "text": "Congressional hearings or legislative pressure regarding FDA rare disease policy",
        "likelihood": "possible",
        "timeframe": "next 3-6 months",
        "basis": "Contradiction between stated priorities and actual decisions affecting vulnerable populations"
      },
      {
        "text": "Pharmaceutical companies will increasingly seek European approval first",
        "likelihood": "likely",
        "timeframe": "ongoing",
        "basis": "EMA's more permissive standards demonstrated by Ebvallo approval"
      },
      {
        "text": "Patient advocacy groups will mobilize against current FDA leadership",
        "likelihood": "likely",
        "timeframe": "next 1-3 months",
        "basis": "Direct impact on patients with limited treatment options and short life expectancy"
      },
      {
        "text": "Atara/Pierre Fabre will appeal or resubmit Ebvallo application with additional data",
        "likelihood": "possible",
        "timeframe": "next 6-12 months",
        "basis": "Significant investment in therapy and existing European approval"
      }
    ],
    "historicalContext": "This situation reflects a recurring tension in FDA history between drug safety and access. The agency has previously faced criticism for both being too permissive (leading to safety scandals) and too restrictive (delaying life-saving treatments). The rare disease space has traditionally received more regulatory flexibility due to small patient populations and limited treatment options, formalized through programs like accelerated approval and breakthrough therapy designation. The current shift appears to reverse recent trends toward greater accommodation for rare diseases, potentially returning to more stringent pre-2010s approval standards despite legislative efforts like the Orphan Drug Act designed to encourage rare disease drug development.",
    "implications": [
      "Reduced pharmaceutical investment in rare disease research due to increased regulatory uncertainty",
      "Potential exodus of rare disease patients seeking treatment in Europe where regulatory standards appear more accommodating",
      "Growing disparity between FDA and European regulatory approaches may fragment global drug development strategies",
      "Increased mortality among rare disease patients who lose access to experimental therapies that might extend survival",
      "Political pressure on the administration to clarify its rare disease policy given contradiction between rhetoric and actions",
      "Possible legal challenges from pharmaceutical companies and patient groups citing arbitrary policy changes",
      "Erosion of FDA's reputation as a science-based agency if decisions appear politically motivated rather than evidence-driven"
    ],
    "generatedAt": "2026-02-26T20:55:26.200Z",
    "model": "anthropic/claude-sonnet-4"
  },
  "articles": [
    {
      "id": "4b8ae1d2-2e14-4fb1-9544-59777e5f0fa5",
      "title": "STAT+: A rare disease drug was approvable, then it wasn’t. Inside a surprise rejection by the FDA",
      "source": "STAT News",
      "url": "https://www.statnews.com/2026/02/25/rare-disease-drug-fda-ebvallo/?utm_campaign=rss",
      "publishedAt": "Wed, 25 Feb 2026 17:57:24 +0000"
    },
    {
      "id": "68a0abf2-d7a5-4530-876d-3335950b0c71",
      "title": "STAT+: Pharmalittle: We’re reading about a puzzling FDA rejection, a Lilly weight loss pill, and more",
      "source": "STAT News",
      "url": "https://www.statnews.com/pharmalot/2026/02/26/fda-lilly-obesity-gilead-hiv-sarepta/?utm_campaign=rss",
      "publishedAt": "Thu, 26 Feb 2026 14:07:15 +0000"
    },
    {
      "id": "7d06d7e2-f681-4c57-8a50-7a92dc7332a0",
      "title": "STAT+: FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad",
      "source": "STAT News",
      "url": "https://www.statnews.com/2026/02/26/makary-fda-rare-disease-vinay-prasad-cnbc/?utm_campaign=rss",
      "publishedAt": "Thu, 26 Feb 2026 15:20:07 +0000"
    },
    {
      "id": "9a8e32d1-c3a6-4a84-bd74-f0f1a225089c",
      "title": "STAT+: FDA rejection is a reality check on agency rhetoric ",
      "source": "STAT News",
      "url": "https://www.statnews.com/2026/02/26/biotech-news-fda-rejection-for-rare-blood-cancer-therapy/?utm_campaign=rss",
      "publishedAt": "Thu, 26 Feb 2026 14:37:38 +0000"
    },
    {
      "id": "b78fadb6-3604-40b9-88ca-72e6e2399107",
      "title": "STAT+: Xenon’s seizure drug study reads out soon. Here’s what to expect",
      "source": "STAT News",
      "url": "https://www.statnews.com/2026/02/26/xenon-seizures-azetukalner-richard-pops-alkermes/?utm_campaign=rss",
      "publishedAt": "Thu, 26 Feb 2026 11:30:00 +0000"
    }
  ],
  "relatedStorylines": [
    "650a4f88-c9e3-4ed5-bbe0-83bb106c1876"
  ]
}